AJOONI BIOTECH LIMITED (AJOONI) financials

AJOONI BIOTECH LIMITED (AJOONI) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.

Incorporated in 2010, Ajooni Biotech Ltd is avegetarian based animal health care solutions company.[1]

Market Cap: ₹52.0Cr.
Current Price: ₹3.02
Stock P/E: 13.1
ROE: 4.28%
ROCE: 6.11%
Book Value: ₹5.29
Dividend Yield: 0.00%
52W High / Low: ₹5.50/2.68

In Jun 2026, AJOONI BIOTECH LIMITED (AJOONI) reported sales ₹63.49 Cr and net profit ₹0.43 Cr.

Annual TTM: sales ₹215 Cr, net profit ₹4 Cr.

Shareholding: Promoters 30.53% (Aug 2026), FIIs 0.00% (Aug 2026), Public 69.47% (Aug 2026), No. of Shareholders 60,170% (Aug 2026).

AJOONI quarterly results (₹ Cr.)
Category	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	25.72	34.03	29.27	31.27	31.74	58.75	60.62	63.49
Expenses	24.95	33.10	28.26	30.56	30.24	55.72	59.61	61.82
Operating Profit	0.77	0.93	1.01	0.71	1.50	3.03	1.01	1.67
OPM %	2.99%	2.73%	3.45%	2.27%	4.73%	5.16%	1.67%	2.63%
Other Income	0.31	0.39	1.34	0.65	0.15	0.32	1.30	0.27
Interest	0.06	0.07	0.06	0.08	0.17	0.18	0.29	0.48
Depreciation	0.23	0.24	0.38	0.25	0.25	0.81	0.90	0.80
Profit before tax	0.79	1.01	1.91	1.03	1.23	2.36	1.12	0.66
Tax %	22.78%	27.72%	19.37%	24.27%	24.39%	30.08%	15.18%	34.85%
Net Profit	0.62	0.73	1.54	0.78	0.93	1.65	0.95	0.43
EPS in Rs	0.04	0.04	0.09	0.05	0.05	0.10	0.06	0.02
Raw PDF	—	—	—	—	—	—	—	—

AJOONI profit and loss (₹ Cr.)
Category	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	40	51	74	74	80	115	182	215
Expenses	39	49	71	72	78	111	175	207
Operating Profit	1	2	3	3	2	4	6	7
OPM %	3.1%	3.2%	4.2%	3.7%	2.8%	3.2%	3.4%	3.4%
Other Income	0	0	0	0	2	2	2	2
Interest	0	1	1	0	1	0	1	1
Depreciation	0	1	1	1	1	1	2	3
Profit before tax	0	0	1	2	3	4	6	5
Tax %	29%	26%	28%	28%	28%	22%	25%	—
Net Profit	0	0	1	1	2	3	4	4
EPS in Rs	0.02	0.02	0.05	0.06	0.12	0.20	0.25	0.23
Dividend Payout %	0%	0%	0%	0%	0%	0%	0%	—

AJOONI balance sheet (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	6	8	10	10	18	18	34	34
Reserves	6	7	6	6	24	25	54	57
Borrowings	5	5	7	5	5	2	2	18
Other Liabilities	1	2	6	7	12	3	5	11
Total Liabilities	18	23	28	29	59	48	95	120
Fixed Assets	1	2	5	6	6	10	11	26
CWIP	0	0	0	0	0	1	0	0
Investments	4	3	1	1	4	2	3	2
Other Assets	13	18	22	22	48	34	80	92
Total Assets	18	23	28	29	59	48	95	120

AJOONI cash flows (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity	-5	-4	1	4	-6	23	-32	-6
Cash from Investing Activity	1	0	-3	-2	-16	8	14	-16
Cash from Financing Activity	-1	3	2	-2	22	-4	25	15
Net Cash Flow	-5	-1	0	-0	0	27	6	-6
Free Cash Flow	-5	-6	-2	2	-8	17	-33	-23
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit	-706%	-353%	71%	125%	-185%	1,047%	-845%	-92%

AJOONI shareholding pattern (%)
Category	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Aug 2026
Promoters	26.89%	26.89%	26.89%	26.89%	26.89%	26.89%	26.89%	30.53%
FIIs	0.18%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Public	72.92%	73.11%	73.11%	73.11%	73.11%	73.11%	73.11%	69.47%
No. of Shareholders	64,102	63,968	63,305	64,305	62,699	61,779	60,675	60,170

AJOONI key ratios
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	44	115	98	68	101	59	52	36
Inventory Days	51	34	46	34	39	80	90	97
Days Payable	12	20	46	39	56	8	13	22
Cash Conversion Cycle	84	129	98	63	83	131	129	111
Working Capital Days	84	105	77	58	94	132	158	93
ROCE %	4%	4%	5%	9%	6%	8%	5%	6%

AJOONIUpdated 18 Oct 2026, 23:38

Ajooni Biotech Limited

AJOONIUpdated 18 Oct 2026, 23:38

Market Cap

₹52.0Cr.

Current Price

₹3.02

High / Low

₹5.50/2.68

Stock P/E

13.1

ROE4.28%

ROCE6.11%

Book Value₹5.29

Face Value₹2.00

Dividend Yield0.00%

About

Incorporated in 2010, Ajooni Biotech Ltd is avegetarian based animal health care solutions company.[1]

Quarterly results

Last reported quarters₹ Cr.

Quarter	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Jun 2023	21	0.13	20.34	0.07	0.21	0.39	-2.56	0.4	0.02
Sep 2023	19.48	0.19	18.85	0.29	0.21	0.52	23.08	0.4	0.02
Dec 2023	20.05	0.12	20.7	1.57	0.21	0.59	23.73	0.44	0.03
Mar 2024	19.58	0.11	17.99	0.26	0.24	1.5	38.67	0.91	0.05
Jun 2024	25.66	0.15	24.7	0.04	0.22	0.63	25.4	0.47	0.03
Sep 2024	25.72	0.06	24.95	0.31	0.23	0.79	22.78	0.62	0.04
Dec 2024	34.03	0.07	33.1	0.39	0.24	1.01	27.72	0.73	0.04
Mar 2025	29.27	0.06	28.26	1.34	0.38	1.91	19.37	1.54	0.09
Jun 2025	31.27	0.08	30.56	0.65	0.25	1.03	24.27	0.78	0.05
Sep 2025	31.74	0.17	30.24	0.15	0.25	1.23	24.39	0.93	0.05
Dec 2025	58.75	0.18	55.72	0.32	0.81	2.36	30.08	1.65	0.1
Mar 2026	60.62	0.29	59.61	1.3	0.9	1.12	15.18	0.95	0.06
Jun 2026	63.49	0.48	61.82	0.27	0.8	0.66	34.85	0.43	0.02

Profit & loss

Annual statement₹ Cr.

Year	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Mar 2015	7	0	7	0	0	0	27	0	0.05
Mar 2016	13	0	13	0	0	0	29	0	0.06
Mar 2017	29	0	28	0	0	0	28	0	0.13
Mar 2018	42	0	41	0	0	0	20	0	0.03
Mar 2019	40	0	39	0	0	0	15	0	0.03
Mar 2020	40	0	39	0	0	0	29	0	0.02
Mar 2021	51	1	49	0	1	0	26	0	0.02
Mar 2022	74	1	71	0	1	1	28	1	0.05
Mar 2023	74	0	72	0	1	2	28	1	0.06
Mar 2024	80	1	78	2	1	3	28	2	0.12
Mar 2025	115	0	111	2	1	4	22	3	0.2
Mar 2026	182	1	175	2	2	6	25	4	0.25
TTM	215	1	207	2	3	5	—	4	0.23

Shareholding pattern

As of Aug 2026%

Holder	Share
Promoters	30.53%
Public	69.47%

Shareholding trend

Ownership over time%

Quarter	Promoters	FIIs	DIIs	Public
Dec 2023	26.44%	0%	—	73.56%
Mar 2024	26.44%	0%	—	73.56%
Jun 2024	26.89%	0%	—	73.11%
Sep 2024	26.89%	0.29%	—	72.82%
Dec 2024	26.89%	0.18%	—	72.92%
Mar 2025	26.89%	0%	—	73.11%
Jun 2025	26.89%	0%	—	73.11%
Sep 2025	26.89%	0%	—	73.11%
Dec 2025	26.89%	0%	—	73.11%
Mar 2026	26.89%	0%	—	73.11%
Jun 2026	26.89%	0%	—	73.11%
Aug 2026	30.53%	0%	—	69.47%

Balance sheet

Assets & liabilities₹ Cr.

Period	Equity Capital	Reserves	Borrowings	Other Liabilities	Total Liabilities	Fixed Assets	CWIP	Investments	Other Assets	Total Assets
Mar 2015	0.24	0	0	1	2	0	0	0	1	2
Mar 2016	0.24	0	1	1	2	0	0	0	2	2
Mar 2017	0.33	1	1	11	13	1	0	6	6	13
Mar 2018	6	5	5	4	19	1	0	6	12	19
Mar 2019	6	6	5	1	18	1	0	4	13	18
Mar 2020	8	7	5	2	23	2	0	3	18	23
Mar 2021	10	6	7	6	28	5	0	1	22	28
Mar 2022	10	6	5	7	29	6	0	1	22	29
Mar 2023	18	24	5	12	59	6	0	4	48	59
Mar 2024	18	25	2	3	48	10	1	2	34	48
Mar 2025	34	54	2	5	95	11	0	3	80	95
Mar 2026	34	57	18	11	120	26	0	2	92	120

Cash flows

Operating, investing & financing₹ Cr.

Period	Operating	Investing	Financing	Net cash flow
Mar 2015	0	0	0	0
Mar 2016	-1	0	1	0
Mar 2017	-3	-2	5	0
Mar 2018	-3	0	8	5
Mar 2019	-5	1	-1	-5
Mar 2020	-4	0	3	-1
Mar 2021	1	-3	2	0
Mar 2022	4	-2	-2	0
Mar 2023	-6	-16	22	0
Mar 2024	23	8	-4	27
Mar 2025	-32	14	25	6
Mar 2026	-6	-16	15	-6

Key ratios

Historical financial ratios

Category	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	40	33	17	25	44	115	98	68	101	59	52	36
Inventory Days	22	14	63	19	51	34	46	34	39	80	90	97
Days Payable	66	27	79	9	12	20	46	39	56	8	13	22
Cash Conversion Cycle	-4	20	1	35	84	129	98	63	83	131	129	111
Working Capital Days	5	9	-29	-1	84	105	77	58	94	132	158	93
ROCE %	28%	18%	37%	10%	4%	4%	5%	9%	6%	8%	5%	6%

Frequently asked questions

Quick answers about this company's financials on Fincrux

What is the market cap of AJOONI BIOTECH LIMITED (AJOONI)?

The reported market capitalisation for AJOONI BIOTECH LIMITED (AJOONI) is ₹52.0Cr. on Fincrux. Figures may update with market data and filings.

What is the current share price of AJOONI?

The current price shown for AJOONI BIOTECH LIMITED (AJOONI) on Fincrux is ₹3.02 with a 52-week high/low of ₹5.50/2.68.

What is the P/E ratio of AJOONI BIOTECH LIMITED (AJOONI)?

The stock P/E for AJOONI BIOTECH LIMITED (AJOONI) is 13.1 on Fincrux, with ROE at 4.28% and ROCE at 6.11%.

What were AJOONI latest quarterly results?

For Jun 2026, AJOONI BIOTECH LIMITED (AJOONI) reported sales ₹63.49 Cr and net profit ₹0.43 Cr (figures in ₹ crore unless noted).

What are AJOONI annual sales and net profit?

For TTM, AJOONI BIOTECH LIMITED (AJOONI) shows sales of ₹215 Cr and net profit of ₹4 Cr on the Fincrux profit & loss statement.

Who owns AJOONI BIOTECH LIMITED (AJOONI)?

Latest shareholding for AJOONI BIOTECH LIMITED (AJOONI) on Fincrux: Promoters 30.53% (Aug 2026), FIIs 0.00% (Aug 2026), Public 69.47% (Aug 2026), No. of Shareholders 60,170% (Aug 2026).

Where can I find AJOONI BIOTECH LIMITED (AJOONI) financials?

AJOONI BIOTECH LIMITED (AJOONI) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.

Does Fincrux show AJOONI balance sheet and cash flow?

Yes. The AJOONI BIOTECH LIMITED (AJOONI) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 18 October 2026 at 23:38